| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/28/2010 | US20100021935 Goodpasture Antigen Binding Protein and Its Detection |
| 01/28/2010 | US20100021931 Fluorescence based reporter construct for the direct detection of TGF-beta receptor activation and modulators thereof |
| 01/28/2010 | US20100021898 Mammalian oocyte development competency granulosa markers and uses thereof |
| 01/28/2010 | US20100021612 Method for the production of fusion proteins in transgenic mammal milk |
| 01/28/2010 | US20100021510 Neuronal exocytosis inhibiting peptides |
| 01/28/2010 | US20100021503 Immunogenic composition |
| 01/28/2010 | US20100021496 Methods, kits, and antibodies for quantitative determination of parathyroid hormone molecules with intact c-terminus |
| 01/28/2010 | US20100021492 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 01/28/2010 | US20100021491 PROTEIN KINASE DEFICIENT, IMMUNOLOGICALLY ACTIVE CMVpp65 MUTANT CELLULAR VACCINES |
| 01/28/2010 | US20100021490 Preparation of soluble N-protein/truncated P-protein complexes or N-proteinssoluble in a virus of the paramyxoviridae family and use thereof in vaccines |
| 01/28/2010 | US20100021489 comprising an RNA sequence capable of specifically binding a polypeptide participating in influenza virus infection of cells |
| 01/28/2010 | US20100021484 Compositions, Methods and Kits Relating to Poxvirus Subunit Vaccines |
| 01/28/2010 | US20100021482 Novel death associated proteins, and thap1 and par4 pathways in apoptosis control |
| 01/28/2010 | US20100021480 Bioactive substance-blood protein conjugate and stabilization of a bioactive substance using the same |
| 01/28/2010 | US20100021477 DESIGN AND GENERATION OF HUMAN DE NOVO pIX PHAGE DISPLAY LIBRARIES |
| 01/28/2010 | US20100021475 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 01/28/2010 | US20100021469 Functional role of adrenomedullin (am) and the gene related product (pamp) in human pathology and physiology |
| 01/28/2010 | US20100021468 Novel mhc class ii restricted t cell epitopes from the cancer anitgen, ny eso-1 |
| 01/28/2010 | US20100021467 Method of detecting a cancer cell by aberrant expression of a human k+ ion channel |
| 01/28/2010 | US20100021465 Boris isoforms and methods of detecting and treating disease |
| 01/28/2010 | US20100021462 Gasp1: a follistatin domain containing protein |
| 01/28/2010 | US20100021457 Detection system and uses therefor |
| 01/28/2010 | US20100021453 Targeting of triacylclycerol synthase gene for tuberculosis treatment |
| 01/28/2010 | US20100021441 Mhc molecule-binding tumor-associated peptides |
| 01/28/2010 | US20100021421 Fusion proteins and methods for modulation of immune response |
| 01/28/2010 | US20100021419 Stable Pharmaceutical Composition Comprising Granulocyte-Colony Stimulating Factor |
| 01/28/2010 | US20100021390 Fluorescent Analogs Of The Islet Amyloid Polypeptide |
| 01/28/2010 | US20100021383 Molecular probe for sphingolipids |
| 01/28/2010 | CA2768782A1 Syndecan-4 is a regulator of rac1-gtp |
| 01/28/2010 | CA2733218A1 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 01/28/2010 | CA2731549A1 Novel compositions and methods |
| 01/28/2010 | CA2731547A1 The tuberculosis rv2386c protein, compositions and uses thereof |
| 01/28/2010 | CA2731499A1 Novel compositions and methods |
| 01/28/2010 | CA2731388A1 Tnfsf single chain molecules |
| 01/28/2010 | CA2731384A1 Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides |
| 01/28/2010 | CA2730804A1 Amyloid .beta. peptide analogues, oligomers thereof, processes for preparing and compositions comprising said analogues or oligomers, and their uses |
| 01/28/2010 | CA2730132A1 Novel angiopoietin derived peptides |
| 01/28/2010 | CA2729296A1 Gip-based mixed agonists for treatment of metabolic disorders and obesity |
| 01/28/2010 | CA2729099A1 Plants with altered root architecture, related constructs and methods involving genes encoding rep2 polypeptides and homologs thereof |
| 01/27/2010 | EP2147970A1 Method for production of acidic substance having carboxyl group |
| 01/27/2010 | EP2147930A2 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147929A2 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147928A2 Peptide-based immunization therapy for treatment of atherosclerososis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147927A2 Use of 131i-tm-601 for the diagnosis and treatment of gliomas |
| 01/27/2010 | EP2147926A1 Truncated human papillomavirus type 18 l1 proteins |
| 01/27/2010 | EP2147680A2 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147679A2 Compositions and methods for modulating blood-brain barrier transport |
| 01/27/2010 | EP2147108A2 Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases |
| 01/27/2010 | EP2147096A2 Modified factor vii polypetides and uses thereof |
| 01/27/2010 | EP2147018A1 Y-receptor agonists |
| 01/27/2010 | EP2147017A1 Functional protein crystals containing a core nano-particle and uses thereof |
| 01/27/2010 | EP2147016A2 Cysteic acid derivatives of anti-viral peptides |
| 01/27/2010 | EP2147015A2 Mutants of cholesterol-dependent cytolysins and uses thereof |
| 01/27/2010 | EP1769085B1 DETECTION OF CELLULAR STRESS using Hmox-1 promoter |
| 01/27/2010 | EP1692186B1 Cancer cell targeting gene delivery method |
| 01/27/2010 | EP1527188B1 Process for the production of increased amounts of correctly folded heterologous protein in inclusion bodies |
| 01/27/2010 | EP1362106B1 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 01/27/2010 | EP1319713B1 Complex |
| 01/27/2010 | EP1206563B1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 01/27/2010 | EP1026941B1 Nepovirus resistance in grapevine |
| 01/27/2010 | CN101636410A Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir |
| 01/27/2010 | CN101636409A Recombinant malaria vaccine |
| 01/27/2010 | CN101633907A Amplification culture method for antigen specific cytotoxic t lymphocytes |
| 01/27/2010 | CN101633692A Methods for making apo-2 ligand using divalent metal ions |
| 01/27/2010 | CN101633691A Hydrogen production associated protein, coding genes thereof and application thereof |
| 01/27/2010 | CN101633690A Hydrogen production associated protein, coding genes thereof and application thereof |
| 01/27/2010 | CN101633689A Peptide selection method |
| 01/27/2010 | CN101633636A Peptidomimetic protease inhibitors |
| 01/27/2010 | CN100584952C Methods and means for delaying seed shattering in plants |
| 01/27/2010 | CN100584950C Chimeric polypeptides and their use |
| 01/27/2010 | CN100584948C Procine circoviruses, vaccines and diagnostic reagents |
| 01/27/2010 | CN100584945C Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 01/27/2010 | CN100584860C A plurality of reconstructing antibiotic peptide and preparation method and application thereof |
| 01/27/2010 | CN100584858C RA antigenic peptides |
| 01/27/2010 | CN100584857C Process of high purity albumin production |
| 01/27/2010 | CN100584343C Medicine health-care usage of globefish I collagen extraction and preparing process thereof |
| 01/26/2010 | US7652195 Alfalfa variety 53V52 |
| 01/26/2010 | US7651656 Melting furnace with agitator and agitator for melting furnace |
| 01/26/2010 | CA2642066C Immuno-interactive fragments of the .alpha.c subunit of inhibin |
| 01/26/2010 | CA2499354C Transcription control factor zhx3 |
| 01/26/2010 | CA2493534C Pegylated t20 polypeptide |
| 01/26/2010 | CA2421588C Tnf receptor-like molecules and uses thereof |
| 01/26/2010 | CA2404237C Methods of investigating, diagnosing, and treating amyloidosis |
| 01/26/2010 | CA2371808C Alteration of flowering time in plants |
| 01/26/2010 | CA2328803C Anti-procalcitonin antibodies and the preparation and use thereof |
| 01/26/2010 | CA2301499C T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
| 01/26/2010 | CA2301175C Collagen mimics |
| 01/26/2010 | CA2230033C Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
| 01/26/2010 | CA2222524C Somatostatin peptides |
| 01/26/2010 | CA2213301C Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
| 01/26/2010 | CA2204666C Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 01/26/2010 | CA2201841C Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 01/26/2010 | CA2188817C Angiogenesis inhibitor |
| 01/26/2010 | CA2188279C Interleukin-15 receptors |
| 01/21/2010 | WO2010009330A1 Nucleobindin i variant protein compositions and methods of use |
| 01/21/2010 | WO2010009319A2 Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| 01/21/2010 | WO2010009227A2 Recombinant pokeweed antiviral proteins, compositions and methods related thereto |
| 01/21/2010 | WO2010009190A1 Methods of treating atherosclerosis |
| 01/21/2010 | WO2010008587A2 A viral nucleocapsid protein as a multifunctional translation initiation factor and increased protein and polypeptide production using same |
| 01/21/2010 | WO2010008558A1 Compounds and methods of inducing apoptosis via interaction with chaperonin cct |